The Immunocytokine F8-IL2 Improves the Therapeutic Performance of Sunitinib in a Mouse Model of Renal Cell Carcinoma-Reference-Cited by-同舟云学术

The Immunocytokine F8-IL2 Improves the Therapeutic Performance of Sunitinib in a Mouse Model of Renal Cell Carcinoma

Author:

Frey Katharina¹,Schliemann Christoph¹²,Schwager Kathrin³,Giavazzi Raffaella⁴,Johannsen Manfred⁵,Neri Dario¹

Affiliation:

1. Department of Chemistry and Applied Biosciences, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland

2. Department of Medicine A-Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany

3. Philochem AG, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland

4. Department of Oncology, Mario Negri Institute for Pharmacological Research, Via Giuseppe La Masa 19, 20156 Milano, Italy

5. Department of Urology, Charité Berlin, Berlin, Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Renal cell carcinoma;Rini;Curr Opin Oncol,2008

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献